Corange's course correction takes shape

Noteworthy

Corange Ltd. appears to be moving swiftly to implement its newly stated strategy of finding near-term market opportunities, with the announcement of a collaboration between its Boehrlnger Mannhelm Pharmaceuticals Corp. unit and Gensia Pharmaceuticals Inc. to develop a Geomatrix version of nifedipine...